On ECHEMI
Home > Drugs > Blepharospasm-oromandibular dystonia
Blepharospasm-oromandibular dystonia
Blepharospasm-oromanbular dystonia is also known as Meige’s syndrome or Brueghel syndrome. It is a group of syndromes of unknown cause, mainly manifested by spasms of both eyelids and involuntary movements of facial dystonia. French scholar Heury Meige (1910) first described a group of cases. This disease is dystonia, with paroxysmal tonic contractions of the affected muscle groups, presenting as spasms for seconds to minutes, and then spreading to other parts. Although electrophysiological and MRI studies have speculated that this disease may be related to the midbrain and basal ganglia, the exact cause is still unknown. Some people believe that certain sedatives can also cause the occurrence of this disease.
  • Site of disease:

    Eye and mouth muscles
  • Infectious :

    Not contagious
  • Frequent population:

    Middle-aged and elderly people
  • Related symptoms:

    Blepharospasm spasm dry eyes photophobia blepharospasm
  • Concurrent disease:

Related Drugs
Racemic anisodamine eye drops
Indication: Used for pseudomyopia in adolescents.
Manufacturer:

Wuhan Wujing Pharmaceutical Co., Ltd.

Racemic anisodamine eye drops
Indication: Used for pseudomyopia in adolescents.
Botulinum toxin type A for injection
Indication: Blepharospasm, hemifacial spasm and related focal dystonias.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.